Artículo
Original
The effect of Spirulina algae on the immune response of SPF chickens to
commercial inactivated Newcastle vaccine in poultry
El
efecto del alga Spirulina sobre la respuesta inmune de pollos SPF inducida por
la vacuna inactivada comercial contra la enfermedad de Newcastle
Mahmoud M. Abotaleb* ORCID: https://orcid.org/0000-0001-9303-539X
Ahlam Mourad
Mohamed S. Abousenna ORCID: https://orcid.org/0000-0003-2202-9544
Amr M. Helal
Samir A. Nassif
Mounir M.
Elsafty
Central
Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center,
Cairo, Egypt.
Autor para correspondencia: m.abotaleb84@yahoo.com;
mohamedsamy2020@hotmail.com
ABSTRACT
The objective of this study was to investigate the effects of Spirulina platensis (SP) powder
supplementation on immune response in SPF chickens. For this purpose, 120 SPF
chicks were randomly clustered into six groups consisting of 20 birds each which
assigned to five groups vaccinated by commercial inactivated Newcastle disease
(ND) vaccine at 21 days of age. The four groups were supplemented with 0.5, 1,
1.5 and 2 g of SP per kg of ration at 7 day of age and other group as control
treatment group. Control unvaccinated
group still without any treatment. Individual blood samples were collected weekly
from all groups, and NDV-HI antibodies were measured using Hemagglutination inhibition (HI) test. After 28 days post-vaccination, ten birds from all groups
were challenged intramuscularly at a dose 0.5 mL/bird containing 106 EID50
of local NDV genotype VII. Challenge virus shedding was detected using real time qrt-PCR of
oropharyngeal swabs that were collected from all challenged chicken groups of
at 3, 5, 7 and 10 days post challenge. Obtained results showed that vaccinated groups of SPF-chickens either
supplied with Spirulina or control treatment group induced positive serological
response as NDV-HI antibody were measured in sera of immunized chicks (7.6, 8,
8.3, 8.9 and 7.4 log2, respectively) at 4 weeks post vaccination
(WPV). Significant differences were observed at
2 WPV in the vaccinated SPF chickens consumed 1, 1.5 and 2 g of SP/kg of ration,
compared to untreated vaccinated group (p<0.05). Immunized SPF chickens
supplied with different SP concentration confer satisfactory protection against
heterologous challenge virus (90%, 100%, 100% and 100% respectively), in
contrast to untreated vaccinated chickens. Different percentages of reduction
of viral shedding (55%, 65%, 76% and 87%) of treated vaccinated chickens with
different concentration of SP were detected, despite untreated group were
reduced 46% from total viral shedding. These findings suggest that dietary
Spirulina has immune-stimulatory effects on the immune system of SPF chickens.
One gram from SP per kg of ration was minimum recommended concentration that
able to exhibit optimum immune response, increase protection against heterologous
strains and able to reduce viral shedding.
Keywords: Spirulina;
Newcastle disease virus; humoral immune response; real-time PCR; vaccination;
serological tests.
RESUMEN
El objetivo de este estudio fue investigar los efectos de la
suplementación con polvo de Spirulina
platensis (SP) sobre la respuesta inmune en pollos SPF. Para este propósito
se agruparon al azar 120 polluelos SPF en seis grupos de 20 aves cada uno, que
se asignaron a cinco grupos vacunados con la vacuna comercial inactivada contra
la enfermedad de Newcastle (ND) a los 21 días de edad. Cuatro grupos se
suplementaron con 0,5; 1; 1,5 y 2 g de SP por kg de ración a los 7 días de
edad, un grupo vacunado sin suplemento y un grupo sin ningún tratamiento.
Semanalmente, se recogieron muestras de sangre individuales de todos los grupos
y se midieron los anticuerpos hemaglutinantes contra el virus Newcastle
(NDV-HI) mediante la prueba de inhibición de la hemaglutinación (HI). 28 días
después de la vacunación, fueron retadas diez aves de cada grupo por vía
intramuscular a una dosis 106 EID50 del genotipo VII del NDV local
en un volumen de 0,5 mL/ave. Se detectó la eliminación del virus mediante
qrt-PCR en hisopos orofaríngeos que se recolectaron en todos los grupos a los
3, 5, 7 y 10 días después del reto. Los resultados obtenidos mostraron que los
grupos vacunados de pollos y suplementados con Espirulina y el grupo de control
vacunado, indujeron una respuesta serológica positiva cuando se determinaron
los anticuerpos NDV-HI en los pollitos inmunizados (7,6; 8; 8,3; 8,9 y 7,4 log2
respectivamente) a las 4 semanas después de la vacunación (SPV). Se observaron
diferencias significativas a las 2 SPV en los pollos vacunados que consumieron
1, 1,5 y 2 g de SP/kg de ración, en comparación con el grupo vacunado no
tratado (p<0,05). Los pollos inmunizados que recibieron diferentes
concentraciones de SP mostraron una protección satisfactoria contra el desafío
heterólogo viral (90%, 100%, 100% y 100% respectivamente), en contraste con los
pollos vacunados no tratados. Se observaron diferentes porcentajes de reducción
de la diseminación viral (55%, 65%, 76% y 87%) entre los pollos vacunados
tratados con diferente concentración de SP. En el grupo no tratado se redujo al
46%. Estos hallazgos sugieren que la Espirulina en la dieta tiene efectos inmunoestimuladores
sobre el sistema inmunitario de los pollos. Un gramo de SP por kg de ración fue
la concentración mínima recomendada para una respuesta inmune óptima, y de esta
forma aumentar la protección contra las cepas heterólogas y disminuir la diseminación
viral.
Palabras
clave:
Spirulina; virus de la enfermedad de Newcastle; respuesta inmune humoral; PCR
en tiempo real; vacunación; pruebas serológicas.
Submitted:
January 28, 2020
Approved:
February 4, 2020
Introduction
Spirulina
platensis (SP) is a blue-green alga having diverse biological activity. Early,
due to high content of highly valuable proteins, indispensable amino acids,
vitamins, beta-carotene and other pigments, mineral substances, indispensable
fatty acids and polysaccharides, SP has been found suitable for use as
bioactive additive.(1)
Recent attention has been given to immune-stimulant role of SP.(2)
In 1994, the first report for immune-modulatory effect of this alga on
mice through enhanced IL-1 antibody production.(3) Chicken diets were contained less than 1%
Spirulina lead to significantly enhance the defense systems for increased
microbial killing, antigen processing and greater T-cell activity.
Subsequently, more researches were investigated the role of Spirulina to
enhance immune system in different animal models as dogs and cats as
well as human.(4)
Newcastle disease virus (NDV) stands behind most of mortalities and morbidities
in poultry.(5)
The infection control depends mainly on vaccination of chickens with the commercial
inactivated NDV vaccine. Many of these vaccine batches are submitted annually
to the Central Laboratory for Evaluation of Veterinary Biologics (CLEVB),
Cairo, Egypt for reviewing its quality. Potency of this type of vaccine is
evaluated routinely by vaccination-challenge test (efficacy) in susceptible SPF
chickens following the protocols.(6)
In this study, protective efficacy of an inactivated Newcastle vaccine
(Ulster 2 strain) is determined in SPF chickens that were supplied with
different concentrations of SP (0.5, 1, 1.5 and 2 g/kg ration) in comparison
with SPF chickens fed with the same ration without any supplement against
heterologous circulating NDV genotype VII.
Material and Methods
Preparation of Spirulina extract: A crude extract was prepared from SP using
a patent-pending procedure. Raw material was extracted two times with 50%
ethanol at 70°C, 45 min each time. Supernatants from both extractions were
combined following centrifugation for 5 min at 1500 g. The ethanol
concentration of the extract was adjusted to 75% by addition of 1 volume of
cold ethanol. Following incubation for several hours at -20°C, perceptible
material was collected by centrifugation at 1500 g and subsequently washed with
cold ethanol. The final extract material was dried and represented a 15% yield
of raw material dry weight.
Experimental Chicken:
Vaccine: The commercial inactivated NDV vaccine
contained (Ulster2C strain) which was used for vaccination of SPF chickens with
one field dose recommended for poultry that was administrated intramuscularly
at a dose of 0.3mL/bird. The batch No. is (L469199) and it's expired by
23/11/2021.
Serum samples: Blood samples were collected from jugular
vein of ten vaccinated SPF chickens from each group and sera were separated to conduct
Hemagglutination inhibition test (HI test).
Virus: Local NDV genotype VII was obtained from
Strain Bank of Central Laboratory for Evaluation of Veterinary Biologics
(CLEVB) which has (accession no.
KM288609) to be used as challenge virus and as heterologous NDV antigen
with a titer of 8 log 2 HA units/mL and used at a final concentration of 4
HA/mL in HI test for the tested serum samples.
Propagation and
titration of NDV genotype VII: It was carried out according
to the manual of the World Organization of Animal Health.(7)
Calculation of Egg
infective dose/50 (EID50) for local NDV genotype VII: It was done
according to the manual of the World Organization of Animal Health.(7)
Serological tests:
Hemagglutination (HA) and HI assays were performed using the standard
microtiter plate method as recommended.(7) The HI tests was carried out with 4 HA units of NDV
genotype VII per well.
Measurement of the
protection efficacy %: By using challenge test
through inoculation of 106 EID50/SPF chickens of NDV
genotype VII intramuscularly at a dose 0.5mL/bird.(7)
Measurement of
viral shedding by RT-qPCR: Oropharyngeal swabs were taken
from all groups of chickens at 3, 5, 7 and 10 days post challenge and prepared
then kept at -80°C till use.(7)
Qrt-PCR: RNA was extracted
from swabs using QIAamp Viral RNA Mini Kit that supplied from Qiagen, Valencia,
CA, USA, Cat. No. 52906. Samples were amplified using Invitrogen superscript®
III platinum® one- step Quantitative RT-PCR Cat. No 11732-088 to investigate the
presence or absence of M gene of ND virus following the manufacture
instructions using primers and probe and reaction condition.(8) The test was conducted in a
CFX 96 touch TM Real time PCR (Table 1).
Table 1. Oligonucleotide primers
used in RT-PCR for detection of NDV M- protein gene.
Primer |
Sequence (5′ - 3′ ) |
Forward
ND-M+4100 |
AGTGATGTGCTCGGACCTTC |
Reverse
ND-M-4220 |
CCTGAGGAGAGAGGCATTTGCTA |
Probe |
HEX-TTCTCTAGCAGTGGGACAGCCTGC-BHQ |
Experimental design: A total 120 SPF chickens
at 7 days old of age were distributed randomly into three groups. The first
group (80 SPF chickens) was allotted into four replicates (20 SPF
chickens/replicate) which were supplemented with different SP concentration
(0.5, 1, 1.5, and 2 g/kg in ration), then vaccinated with NDV vaccine at 21
days old age. The second group (20 SPF chickens) were fed without any
supplement, then vaccinated with the same vaccine at the same age of the
previous group despite, the third group control unvaccinated group (20
chickens) without any treatment.
Individual blood samples were
collected from ten birds of each group weekly between the first and 4 weeks
after inoculation and NDV-HI antibodies were measured in each collected serum
sample by HI test. After 28 days post-vaccination, ten birds from all groups
were challenged intramuscularly at a dose of 0.5 mL/ bird by 106 EID50 of local NDV genotype VII. Oropharyngeal
swabs were taken from all groups of chickens at 3, 5, 7 and 10 days post
challenge.
Ethical approval: Institutional Animal Care
and use committee at Central Laboratory for Evaluation of veterinary Biologics
hereby acknowledge the research manuscript and it has been reviewed under our
research authority and is deemed compliance to bioethical standards in good
faith.
Statistical Analysis: Data generated from
immune responses were subjected to one way analysis of variance (ANOVA).
Variant means were separated post hoc using the least significant difference
(LSD) method;(9) p<0.05 were accepted as significant.
Results
Hemagglutination
inhibition test
The data
revealed from Table 2, showed low mean HI antibody titers at one week post vaccination
(WPV) for all vaccinated groups. Mean HI antibody titer increased gradually
till reached its peak at 4th WPV to be 7.6, 8, 8.3, 8.9 and 7.4 log2
in the sera of vaccinated SPF chickens supplemented with 0.5, 1, 1.5 and 2 g
SP/kg ration and control treatment group, respectively. Vaccinated SPF chickens
were consumed SP algae in ration exhibited higher immune response than those
induced by the other group. There were a significant difference at 2nd
WPV in all groups consumed 1, 1.5 and 2 g of SP in ration to other vaccinated
chickens fed ration without SP as shown in Table 3.
Table 2.
Mean ND-HI antibody titer produced by sera of SPF chickens after 1, 2, 3 and 4
weeks post vaccination with one dose of commercial ND vaccine.
Group of
chickens |
Spirulina (g/kg)
in ration |
Mean HI antibody
titer (log2) |
|||
1st
WPV |
2nd
WPV |
3rd
WPV |
4th
WPV |
||
Vaccinated
chickens were supplemented with different SP g/kg in ration |
0.5
g/kg |
1.2 ±1.09280 |
4.3 ±0.67495 |
6.4 ±0.69921 |
7.6 ±0.51640 |
1
g/kg |
1.4
±0.96609 |
5.1 ±0.87560 |
7.3 ±0.67495 |
8 ±0.73786 |
|
1.5
g/kg |
1.6 ±0.84327 |
5.4 ±0.69921 |
7.4 ±0.51640 |
8.3 ±0.67495 |
|
2
g/kg |
2 ±0.94281 |
5.9 ±0.56765 |
7.8 ±0.63246 |
8.9 ±0.73786 |
|
Vaccinated
chickens without SP supplement in ration |
1.2 ±1.03280 |
4.1 ±0.87560 |
6 ±0.81650 |
7.4 ±0.69921 |
|
Control
non-vaccinated chickens |
0 |
0 |
0 |
0 |
Table 3. Significant
values between vaccinated chickens
without SP supplement in ration to Vaccinated chickens consumed different concentration SP g/kg of ration
|
Significant
values |
||||
Group |
Vaccinated chickens supplied with different SP g/kg
of ration |
||||
WPV |
0.5
g/kg |
1 g/kg |
1.5
g/kg |
2 g/kg |
|
Vaccinated
chickens without Spirulina supplement in ration |
1 WPV |
0.961 |
0.553 |
0.179 |
0.513 |
2 WPV |
0.649 |
0.005 |
0.000 |
0.000 |
|
3 WPV |
0.365 |
0.000 |
0.000 |
0.000 |
|
4 WPV |
0.074 |
0.000 |
0.000 |
0.000 |
Significance
difference ≤ 0.005
Protection
efficacy
It was found that all vaccinated SPF chickens
groups consumed SP in ration with different concentrations (0.5, 1, 1.5 and 2
g/kg ration) were protected the infection against local NDV genotype VII with a
different percentage: 90, 100, 100 and 100%, respectively. The group fed
without SP has less protection% reached 80% in contrast to the control group
that showed 100% mortality (Table 4).
Table 4.
Protection % of SPF chickens after 4 weeks post vaccination with one dose of
commercial ND vaccine following challenge by local NDV genotype VII.
Groups |
Total mortality |
Protection% |
|
Spirulina
g/kg in ration for vaccinated chickens |
0.5
g/kg |
1/10 |
90% |
1
g/kg |
0/10 |
100% |
|
1.5
g/kg |
0/10 |
100% |
|
2
g/kg |
0/10 |
100% |
|
Vaccinated
chickens without Spirulina supplement |
2/10 |
80% |
|
Control
non vaccinated |
5/5 |
0% |
Viral shedding
Oropharyngeal swabs were collected from all
groups after 3, 5, 7 and 10 days post challenge (DPC) examined by real time
RT-PCR to calculate viral Shedding of Local NDV genotype VII. The exhibited
data from Table 5 and Figure 1 showed the challenged vaccinated chickens
released the virus with low titers in comparison to unvaccinated challenged
chickens. The reduction of viral shedding reached 3.95, 4.65, 5.45, 6.25 and
3.3 log10 in challenged vaccinated chicken consumed Spirulina algae 0.5,
1, 1.5 and 2 g/kg of ration and the other challenged vaccinated not treated
respectively.
Table 5. Reduction
in viral shedding (log10) from SPF chickens after 4 weeks post
vaccination with one dose of commercial ND vaccine following challenge by local
NDV genotype VII.
Group of
chickens |
Spirulina g/kg
in ration |
Titer of
Shedding Virus titer (log10) |
|||||
3rd
DPC |
5th
DPC |
7th DPC |
10th
DPC |
Mean viral
shedding |
Reduction in
viral shedding |
||
Vaccinated
chickens were supplemented with different SP g/kg in ration |
0.05% |
4 |
4.1 |
3 |
1.8 |
3.2 |
3.95
(55%) |
0.1% |
3.3 |
3.1 |
2.3 |
1.4 |
2.5 |
4.65
(65%) |
|
0.15% |
2.1 |
2.4 |
1.6 |
1 |
1.7 |
5.45
(76%) |
|
0.2% |
1 |
1.3 |
0.9 |
0.4 |
0.9 |
6.25
(87%) |
|
Vaccinated
chickens without SP supplement in ration |
4.8 |
4.6 |
4 |
2 |
3.85 |
3.3
(46%) |
|
Control
non-vaccinated chickens |
7.1 |
7.2 |
- |
- |
7.15 |
0 |
Fig. 1. Amplification curve obtained during RT-PCR Positive
control (accession no. KM288609): (1) (challenged SPF chickens without
treatment), (2), (3), (4) and (5) SPF chickens were treated with 0.5, 1, 1.5
and 2 g of SP/kg ration, and negative control (non-infected allantoic fluid).
Discussion
Spirulina is a cyanobacterium species.(10)
In poultry, some recent studies have shown that feeding SP is responsible for
improvement of immune functions, subsequently increased disease resistance,
improved survival and growth rates.(3)
In this study, the immunostimulant effect of Spirulina was assessed
through vaccination of SPF chickens with commercial inactivated NDV vaccine
which clustered into five groups (20 SPF chickens/group). Five groups were
supplied with different SP grams (0.5, 1, 1.5 and 2) per kg of ration
respectively, in comparison with control treatment group which agreed with some
researchers.(11)
Blood samples were collected from vaccinated SPF chickens weekly till 4 weeks
after inoculation, and ND-HI antibodies were measured in collected sera by HI
test. The obtained results pointed that all vaccinated groups of SPF-chicks
induced high seroconversion response when ND-HI antibodies were measured in
sera of immunized chicks at 3 and 4 WPV. An arithmetic mean of ≥6 log of HI
antibodies in serum samples collected 3-4 weeks after vaccination is required
for approval.(7) Despite, vaccinated SPF chickens were consumed SP in
ration exhibited higher immune response than that induced by control treatment
group which agreed with Egorova et al,(12) that
proved the selenium enriched phycocyanin (Se-PC) from food microalgae Spirulina
demonstrated significantly increased specific IgG response found the dietary SP increase IgG level in
sera of vaccinated chickens.(13)
Significance between vaccinated SPF chickens groups consumed different
SP grams to untreated group exhibited a significance difference (p≤0.005) at 2
WPV of all treated groups except SPF chickens consumed SP with a 0.5 g in kg of
ration.
The protective efficacy of inactivated NDV vaccine containing (Ulster 2C
strain) were measured through challenging all vaccinated chickens by
heterologous local NDV genotype VII,(7) stating that an effective ND poultry vaccine should
protect at least 90% of vaccinated chickens from death. Another interesting finding was all vaccinated SPF
chickens consumed different SP grams confer satisfactory protection which
ranged 90-100% against heterologous NDV genotype VII despite, 0.5 g from
Spirulina did not revealed significance difference in HI titer to untreated
group. These results matched with studies that reported that Spirulina is
capable to enhancing non-specific immune responses as well as that the
ingestion SP enhanced cell mediated immunity.(14,15,16) They revealed the SP produces an
immunostimulating effect by enhancing the resistance of humans, mammals,
chickens and fish to infections. The vaccinated SPF chickens still untreated
couldn't induce the satisfactory protection level which agreed with the same
results obtained by Sedeik et al,(17)
who said that the ND homologous vaccine containing the challenge virus was
better for clinical protection than the heterologous vaccine in terms of
mortality and body weight loss.
Detection of the oropharyngeal (tracheal) viral shedding post challenge
in vaccinated and control groups revealed that, vaccinated SPF chickens groups
consumed different SP concentration (0.5, 1, 1.5 and 2g/kg of ration) showed a
decrease in the tracheal viral shedding than vaccinated untreated group with a
percentage of 55%, 65%, 76%, 87% and 46% of the total collected samples,
respectively, but cannot completely prevent viral shedding which agreed with
Elshazly,(18) who
tested the viral shedding in vaccinated chickens after challenge with a NDV
genotype VII, and they showed that shedding was significantly reduced in
vaccinated groups in comparison with the unvaccinated group but not completely
prevented the ND outbreak.
These findings suggest that dietary Spirulina
has immune-stimulatory effects on the immune system of SPF chickens. One gram
from SP per kg of ration was minimum recommended concentration that able to
exhibit optimum immune response, increase protection efficacy against
heterologous strains and able to reduce viral shedding.
References
1. Anusuya-Devi
M, Subbulakshimi G, Madhavi-Devi K, Venkataram LV. Studies on the Proteins of Mass cultivated Blue-green
Alga (Spirulina platensis). J Agric
Food Chem 1981;29:522-5.
2. Hironobu W,
Kazuki O, Asmi C, Tassakkam T, Masahiro S. Immunostimulant effects of dietary Spirulina platensis on carp, Cyprinus
carpio. Aquaculture 2006;258:157-63.
3. Hayashi O,
Hirahashi T, Katoh T, Miyajima H, Hirano T, Okuwaki Y. Class specific influence of dietary Spirulina platensis on antibody
production in mice. J Nutr Sci Vitaminol
(Tokyo). 1998;44:841-51.
4. Hayashi O,
Ishii K, Kawamura C, YenHei S, YeBao N, Hirahashi T, Katoh T. Enhancement of mucosal immune functions by dietary
Spirulina plantensis in human and animals. Nutrition Sci 2004;7:31-4.
5.
OIE. World Organization for Animal Health. Chapter 2,3,14 Newcastle
disease. Manual of diagnostic tests and vaccines for
terrestrial animals (mammals, birds, bees) 7th edition, Volume 1. Paris: OIE; 2012.
P. 555-73. Available from:
https://www.oie.int/.
6. European
Directorate for the Quality of Medicines and Healthcare. European Pharmacopoeia.
Monograph No. 870
Inactivated Newcastle Disease Vaccines. 9th ed. Strasbourg, France:
EDQM; 2017. Available from: https://www.edqm.eu/en.
7. OIE.
World Organization for Animal Health. Chapter 3,3,14
Newcastle disease. Manual of diagnostic tests and vaccines for terrestrial animals
(mammals, birds and bees) 8th edition, Volume 1. Paris: OIE; 2018.
P. 964-83. Available from: https://www.oie.int/.
8. Kim LM, King
DL, Suarez DL, Wong CW, Afonso CL. Characterization of Class I Newcastle Disease Virus
Isolates from Hong Kong Live Bird Markets and Detection Using Real-Time Reverse
Transcription-PCR. J Clin Microbiol 2007;45:1310-4.
9. Okafor LC. Biometry - Basic Principles and Approaches. Onitsha,
Nigeria: Geelink Publishers; 1992.
10. Hirahashi T,
Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. Activation of the human innate immune system by
Spirulina: augmentation of interferon production and NK cytotoxicity by oral
administration of hot water extract of Spirulina plantesis. Int
Immunopharmacol 2002;2:423-34.
11. Al-Batshan HA, Al-Mufarrej SI,
Al-Homaidan AA, Qureshi, MA. Enhancement of chicken macrophage phagocytic function
and nitrite production by dietary Spirulina
platensis. Immunopharmacol Immunotoxicol. 2001;23(2):281-9.
12. Egorova EA,
Gmoshinskii IV, Zorin SN, Mazo V. Studies of immunomodulation caused by selenium-enriched phycocyanin.
Vopr Pitan. 2006;75(2):19-21.
13. Katayama Sh,
Kayahara Y, Watanabe T. Enhancement
of Immunological Responses by Dietary Arthrospira platensis and Possibility of
Field Applications as Alternative to Antibiotics in Broiler Chicken. Am J Anim Vet Sci. 2016;11(1):18-24.
Doi: 10.3844/ajavsp.2016.18.24.
14. Duncan PL, Klesius PH. Effects of feeding
Spirulina on specific and nonspecific immune responses of channel catfish. 1996; 8(4):
308-313. Available from: https://doi.org/10.1577/1548-8667(1996)008<0308:EOFSOS>2.3.CO;2.
15. Løbner M,
Walsted A, Larsen R, Bendtzen K, Nielsen CH. Enhancement of human adaptive immune responses by
administration of a high-molecular-weight polysaccharide extract from the
cyanobacterium Arthrospira platensis. J Med Food. 2008;11(2):313-22.
16. Blinkova LP,
Gorobets OB, Baturo AP. Biological
activity of Spirulina. Zh Mikrobiol Epidemiol Immunobiol. 2001;2(2):114-8.
17. Sedeik ME, Elbestawy AR, El-Shall NA, Abd El-Hack ME, Saadeldin IM, Swelum AA.
Comparative efficacy of commercial inactivated Newcastle disease virus vaccines
against Newcastle disease virus genotype VII in broiler chickens. Poult Sci.
2019;98(5):2000-7. doi: 10.3382/ps/pey559.
18. Elshazly
MM. Studies on the role of free living birds in the epidemiology of prevalent
diseases in poultry farms [dissertation]. Giza, Egypt: Faculty of Veterinary
Medicine, Cairo University; 2016.
Conflict
of interest
The authors
whose names are listed immediately above certify that they have no affiliations
with or involvement in any organization or entity with any financial interest
(such as honoraria; educational grants; participation in speakers’ bureaus;
membership, employment, consultancies, stock ownership, or other equity
interest; and expert testimony or patent-licensing arrangements), or
non-financial interest (such as personal or professional relationships,
affiliations, knowledge or beliefs) in the subject matter or materials
discussed in this manuscript.
* BVetMed. PhD of virology. Researcher
in Central Laboratory for Evaluation of Veterinary Biologics.